Full text

Turn on search term navigation

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Nearly 5% of the Shenqi Fuzheng Injection’s dry weight comes from the secondary metabolites of Radix codonopsis and Radix astragali. However, the chemical composition of these metabolites is still vague, which hinders the authentication of Shenqi Fuzheng Injection (SFI). Ultra-high performance liquid chromatography with a charged aerosol detector was used to achieve the profiling of these secondary metabolites in SFI in a single chromatogram. The chemical information in the chromatographic profile was characterized by ion mobility and high-resolution mass spectrometry. Polygonal mass defect filtering (PMDF) combined with Kendrick mass defect filtering (KMDF) was performed to screen potential secondary metabolites. A total of 223 secondary metabolites were characterized from the SFI fingerprints, including 58 flavonoids, 71 saponins, 50 alkaloids, 30 polyene and polycynes, and 14 other compounds. Among them, 106 components, mainly flavonoids and saponins, are contributed by Radix astragali, while 54 components, mainly alkaloids and polyene and polycynes, are contributed by Radix codonopsis, with 33 components coming from both herbs. There were 64 components characterized using the KMDF method, which increased the number of characterized components in SFI by 28.70%. This study provides a solid foundation for the authentification of SFIs and the analysis of its chemical composition.

Details

Title
Authentication of Shenqi Fuzheng Injection via UPLC-Coupled Ion Mobility—Mass Spectrometry and Chemometrics with Kendrick Mass Defect Filter Data Mining
Author
Wu, Xingdong 1 ; Liu, Yaowen 2 ; Zhang, Zijia 1 ; Ou, Zhihuang 3 ; Wang, Guoxiang 3 ; Zhang, Tengqian 4 ; Long, Huali 1 ; Min, Lei 1   VIAFID ORCID Logo  ; Liu, Liangfeng 3 ; Huang, Wenhua 3 ; Hou, Jinjun 1 ; Wu, Wanying 5 ; De-an, Guo 5 

 National Engineering Research Center of TCM Standardization Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; [email protected] (X.W.); [email protected] (Y.L.); [email protected] (Z.Z.); [email protected] (T.Z.); [email protected] (H.L.); [email protected] (M.L.); [email protected] (D.-a.G.) 
 National Engineering Research Center of TCM Standardization Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; [email protected] (X.W.); [email protected] (Y.L.); [email protected] (Z.Z.); [email protected] (T.Z.); [email protected] (H.L.); [email protected] (M.L.); [email protected] (D.-a.G.); School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210029, China 
 Limin Pharmaceutical Factory, Livzon Group Limited, Shaoguan 512028, China; [email protected] (Z.O.); [email protected] (G.W.); [email protected] (L.L.); [email protected] (W.H.); Guangdong Corporate Key Laboratory of High-End Liquid Medicine R&D, Industrilization, Shaoguan 512028, China 
 National Engineering Research Center of TCM Standardization Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; [email protected] (X.W.); [email protected] (Y.L.); [email protected] (Z.Z.); [email protected] (T.Z.); [email protected] (H.L.); [email protected] (M.L.); [email protected] (D.-a.G.); University of Chinese Academy of Sciences, Beijing 100049, China 
 National Engineering Research Center of TCM Standardization Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; [email protected] (X.W.); [email protected] (Y.L.); [email protected] (Z.Z.); [email protected] (T.Z.); [email protected] (H.L.); [email protected] (M.L.); [email protected] (D.-a.G.); Limin Pharmaceutical Factory, Livzon Group Limited, Shaoguan 512028, China; [email protected] (Z.O.); [email protected] (G.W.); [email protected] (L.L.); [email protected] (W.H.) 
First page
4734
Publication year
2022
Publication date
2022
Publisher
MDPI AG
e-ISSN
14203049
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2700696332
Copyright
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.